Global NK Cell Therapy Competitive Landscape Professional Research Report 2024
Research Summary
NK cell therapy, or Natural Killer cell therapy, is an emerging form of immunotherapy that harnesses the body＇s own immune system to combat cancer and other diseases. Natural Killer (NK) cells are a type of immune cell that plays a crucial role in detecting and destroying abnormal or infected cells, including cancer cells. NK cell therapy involves the isolation and expansion of these specialized immune cells from a patient＇s own body or a donor source and their subsequent infusion into the patient. The expanded NK cells are engineered or activated to enhance their ability to recognize and target cancer cells more effectively. NK cell therapy has shown promise in various cancer treatments, providing a targeted and potent immunotherapeutic approach that can work alongside or in conjunction with other cancer therapies to combat the disease and improve patient outcomes.
According to DIResearch's in-depth investigation and research, the global NK Cell Therapy market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of NK Cell Therapy include Nektar Therapeutics, Innate Pharma, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of NK Cell Therapy. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global NK Cell Therapy market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the NK Cell Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of NK Cell Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of NK Cell Therapy Include:
Nektar Therapeutics
Innate Pharma
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech
NK Cell Therapy Product Segment Include:
NK Cell Therapies
NK Cell Directed Antibodies
NK Cell Therapy Product Application Include:
Cancer
Gastrointestinal Diseases
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global NK Cell Therapy Industry PESTEL Analysis
Chapter 3: Global NK Cell Therapy Industry Porter’s Five Forces Analysis
Chapter 4: Global NK Cell Therapy Major Regional Market Size and Forecast Analysis
Chapter 5: Global NK Cell Therapy Market Size and Forecast by Type and Application Analysis
Chapter 6: North America NK Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe NK Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China NK Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) NK Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America NK Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa NK Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global NK Cell Therapy Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 NK Cell Therapy Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 NK Cell Therapy Product by Type
- 1.2.1 Global NK Cell Therapy Market Size by Type, 2023 VS 2024 VS 2030
- 1.2.2 NK Cell Therapies
- 1.2.3 NK Cell Directed Antibodies
- 1.3 NK Cell Therapy Product by Application
- 1.3.1 Global NK Cell Therapy Market Size by Application, 2023 VS 2024 VS 2030
- 1.3.2 Cancer
- 1.3.3 Gastrointestinal Diseases
- 1.3.4 Others
- 1.4 Global NK Cell Therapy Market Revenue Analysis (2019-2030)
- 1.5 NK Cell Therapy Market Development Status and Trends
- 1.5.1 NK Cell Therapy Industry Development Status Analysis
- 1.5.2 NK Cell Therapy Industry Development Trends Analysis
- 2 NK Cell Therapy Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 NK Cell Therapy Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global NK Cell Therapy Market Analysis by Regions
- 4.1 NK Cell Therapy Overall Market: 2023 VS 2024 VS 2030
- 4.2 Global NK Cell Therapy Revenue and Forecast Analysis (2019-2030)
- 4.2.1 Global NK Cell Therapy Revenue and Market Share by Region (2019-2024)
- 4.2.2 Global NK Cell Therapy Revenue Forecast by Region (2025-2030)
- 5 Global NK Cell Therapy Market Size by Type and Application
- 5.1 Global NK Cell Therapy Market Size by Type
- 5.2 Global NK Cell Therapy Market Size by Application
- 6 North America
- 6.1 North America NK Cell Therapy Market Size and Growth Rate Analysis (2019-2030)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America NK Cell Therapy Market Size by Type
- 6.4 North America NK Cell Therapy Market Size by Application
- 6.5 North America NK Cell Therapy Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe NK Cell Therapy Market Size and Growth Rate Analysis (2019-2030)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe NK Cell Therapy Market Size by Type
- 7.4 Europe NK Cell Therapy Market Size by Application
- 7.5 Europe NK Cell Therapy Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China NK Cell Therapy Market Size and Growth Rate Analysis (2019-2030)
- 8.2 China Key Manufacturers Analysis
- 8.3 China NK Cell Therapy Market Size by Type
- 8.4 China NK Cell Therapy Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) NK Cell Therapy Market Size and Growth Rate Analysis (2019-2030)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) NK Cell Therapy Market Size by Type
- 9.4 APAC (excl. China) NK Cell Therapy Market Size by Application
- 9.5 APAC (excl. China) NK Cell Therapy Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Indonesia
- 9.5.6 Vietnam
- 9.5.7 Malaysia
- 9.5.8 Thailand
- 10 Latin America
- 10.1 Latin America NK Cell Therapy Market Size and Growth Rate Analysis (2019-2030)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America NK Cell Therapy Market Size by Type
- 10.4 Latin America NK Cell Therapy Market Size by Application
- 10.5 Latin America NK Cell Therapy Market Size by Country
- 10.5.1 Mecixo
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa NK Cell Therapy Market Size and Growth Rate Analysis (2019-2030)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa NK Cell Therapy Market Size by Type
- 11.4 Middle East & Africa NK Cell Therapy Market Size by Application
- 11.5 Middle East & Africa NK Cell Therapy Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Market Competition by Manufacturers
- 12.1 Global NK Cell Therapy Market Revenue by Key Manufacturers (2020-2024)
- 12.2 NK Cell Therapy Competitive Landscape Analysis and Market Dynamic
- 12.2.1 NK Cell Therapy Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Nektar Therapeutics
- 13.1.1 Nektar Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Nektar Therapeutics NK Cell Therapy Product Portfolio
- 13.1.3 Nektar Therapeutics NK Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.2 Innate Pharma
- 13.2.1 Innate Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Innate Pharma NK Cell Therapy Product Portfolio
- 13.2.3 Innate Pharma NK Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.3 Affimed
- 13.3.1 Affimed Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Affimed NK Cell Therapy Product Portfolio
- 13.3.3 Affimed NK Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.4 Chipscreen Biosciences
- 13.4.1 Chipscreen Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Chipscreen Biosciences NK Cell Therapy Product Portfolio
- 13.4.3 Chipscreen Biosciences NK Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.5 Fate Therapeutics
- 13.5.1 Fate Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Fate Therapeutics NK Cell Therapy Product Portfolio
- 13.5.3 Fate Therapeutics NK Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.6 Glycostem Therapeutics
- 13.6.1 Glycostem Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Glycostem Therapeutics NK Cell Therapy Product Portfolio
- 13.6.3 Glycostem Therapeutics NK Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.7 Dragonfly Therapeutics
- 13.7.1 Dragonfly Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Dragonfly Therapeutics NK Cell Therapy Product Portfolio
- 13.7.3 Dragonfly Therapeutics NK Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.8 Kiadis Pharma
- 13.8.1 Kiadis Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Kiadis Pharma NK Cell Therapy Product Portfolio
- 13.8.3 Kiadis Pharma NK Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.9 NantWorks
- 13.9.1 NantWorks Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 NantWorks NK Cell Therapy Product Portfolio
- 13.9.3 NantWorks NK Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.10 Nkarta Therapeutics
- 13.10.1 Nkarta Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Nkarta Therapeutics NK Cell Therapy Product Portfolio
- 13.10.3 Nkarta Therapeutics NK Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.11 Fortress Biotech
- 13.11.1 Fortress Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Fortress Biotech NK Cell Therapy Product Portfolio
- 13.11.3 Fortress Biotech NK Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 14 Industry Chain Analysis
- 14.1 NK Cell Therapy Industry Chain Analysis
- 14.2 NK Cell Therapy Industry Raw Material and Suppliers Analysis
- 14.2.1 Upstream Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 NK Cell Therapy Typical Downstream Customers
- 14.4 NK Cell Therapy Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook